group:opioid-epidemic - The NIC Collaboration Hub2024-03-28T23:16:55Zhttps://hub.nic-us.org/groups/opioid-epidemic/resources/feed/tag/group%3Aopioid-epidemicThe Best Drug Rehabs in Florida: What Resources Are Available?https://hub.nic-us.org/groups/opioid-epidemic/resources/the-best-drug-rehabs-in-florida-what-resources-are-available2021-03-19T16:34:31.000Z2021-03-19T16:34:31.000ZHub Adminhttps://hub.nic-us.org/members/NIC<div><p>Drug problems are increasingly common in a world where illicit substances have become widely available. Thankfully, the increased focus on drug problems in recent years has led to the introduction of a wide range of treatment methods that have proven to be effective. Additionally, many treatment centers in Florida have opened in recent years. Read on to learn how you can pick the best drug rehabs in Florida that can effectively resolve the addiction challenges you are facing.</p>
<p><a href="https://www.chapelhilldetox.com/resources/" target="_blank">View the website >></a></p></div>A Cross Sector Approach to Removing Legal and Policy Barriers to Opioid Agonist Treatmenthttps://hub.nic-us.org/groups/opioid-epidemic/resources/a-cross-sector-approach-to-removing-legal-and-policy-barriers-to-2021-02-02T17:57:54.000Z2021-02-02T17:57:54.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>Executive Summary:</p>
<p>The opioid overdose epidemic is one of the most urgent public health issues in the United States today, killing nearly 50,000 people every year and contributing to a variety of other health complications. Opioid agonist treatment (OAT) is the provision of medications that activate the opioid receptors to prevent withdrawal and reduce cravings for opioids and is the safest and most effective treatment for people with opioid use disorders. Currently, the two medications approved for OAT are methadone and buprenorphine. Opioid agonist treatment is credited with dramatically reducing risk of opioid overdose deaths and improving other health outcomes.</p>
<p>Despite its demonstrated effectiveness, barriers to OAT access arise in various areas of law and policy, restricting access for many in need. The Network for Public Health Law convened the Cross-Sector Attorneys for Health, a group of more than a dozen public health attorneys seeking to bring cross-cutting areas of legal and policy expertise to address critical public health issues. The group identified the overdose crisis and OAT access as a high priority requiring immediate attention and met monthly over the past 18 months to develop the findings and recommendations in this paper. We hope advocates across different legal and policy areas will utilize it to address OAT access barriers in their areas of work.</p>
<p>This paper identifies barriers to OAT access and potential solutions to improve OAT uptake in eight sectors. We do not represent this document as comprehensive of all that must be<br />done, but we do believe the barriers described are the most significant and the solutions proposed would be the most impactful.</p>
<p><a href="https://www.networkforphl.org/wp-content/uploads/2020/12/Cross-Sector-Approach-to-Removing-Barriers-to-OAT.pdf" target="_blank">View the report >></a></p></div>Medications for Opioid Use Disorder Improve Patient Outcomeshttps://hub.nic-us.org/groups/opioid-epidemic/resources/medications-for-opioid-use-disorder-improve-patient-outcomes2021-01-05T18:19:54.000Z2021-01-05T18:19:54.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>Overview:</p>
<p>In 2018, opioid overdoses in the United States caused one death every 11 minutes, resulting in nearly 47,000 fatalities.1 The most effective treatments for opioid use disorder (OUD) are three medications approved by the Food and Drug Administration (FDA): methadone, buprenorphine, and naltrexone.2 Using one of these can reduce a person’s risk of illicit opioid use and fatal overdoses,3 which underscores the need to increase access to medications for people with OUD.4 While many people with OUD may also benefit from counseling, medications are proved to be beneficial even without such counseling services. Unfortunately, medications often are not available due to a lack of providers who can deliver these therapies, inadequate funding and reimbursement for treatment programs, and the stigma surrounding OUD that can keep people from accessing medications.5 It is therefore critical for patients, providers, and policymakers to understand the efficacy of these medications in order to ensure that people with OUD have access to this evidence-based treatment.</p>
<p>OUD is a chronic medical condition caused by the recurrent use of opioids, including prescription drugs such as oxycodone and hydrocodone, and illicit substances such as heroin or fentanyl. OUD includes dysfunction of the brain’s reward system, motivation, memory, and related circuitry and is manifested by individuals “pathologically pursuing reward and/or relief by substance use and other behaviors,” according to the American Society of Addiction Medicine. As with other chronic, relapsing conditions, the clinical course of OUD often includes periods of exacerbation and remission that may continue throughout a person’s lifetime.6</p>
<p><a href="https://www.pewtrusts.org/en/research-and-analysis/fact-sheets/2020/12/medications-for-opioid-use-disorder-improve-patient-outcomes?utm_campaign=2020-12-23+Rundown&utm_medium=email&utm_source=Pew" target="_blank">Read the fact sheet >></a></p></div>Executive Order Saving Lives Through Increased Support for Mental and Behavioral Health Needs Reporthttps://hub.nic-us.org/groups/opioid-epidemic/resources/executive-order-saving-lives-through-increased-support-for-mental2021-01-05T18:15:39.000Z2021-01-05T18:15:39.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>Executive Summary:</p>
<p>On October 5, 2020, President Trump signed Executive Order (EO) 13594, Saving Lives Through Increased Support for Mental and Behavioral Health Needs. It reflects the Administration’s dedication to preventing the tragedy of suicide, ending the opioid crisis, and improving mental and behavioral health. As such, the Administration has placed a great emphasis on helping those individuals who are most susceptible, from a mental health standpoint, to prolonged state and local COVID-19 restrictions. Since mental illnesses and substance use disorders (SUDs) can be a risk for all Americans equally, helping people with these vulnerabilities has broad bipartisan support. The EO highlights the exacerbation of emotional needs stemming from interpersonal and environmental stressors caused by the COVID-19 pandemic and the subsequent disruption of services, and provides a blueprint to alleviate these ongoing challenges.</p>
<p>The goal is to reduce the number of immediate life-threatening situations related to mental illness and SUDs through increased education, crisis intervention, follow-up and support services, and increased telehealth and online behavioral health services (i.e. services for a broad range of supports for people with mental illness, SUDs, and other conditions and across the age spectrum from youth to older adults), while utilizing both public and private resources. The EO orders the creation of a Coronavirus Mental Health Working Group (Working Group) to examine existing protocols and programs, and outline a plan for improving mental health functioning by assisting public and private stakeholders and agencies to maximize therapeutic support, including face-toface in-person services, to reduce the negative impact of COVID-19. This Report sets forth actions to date, as well as recommendations for future activity to address these critical issues.</p>
<p><a href="https://www.samhsa.gov/sites/default/files/saving-lives-mental-behavioral-health-needs.pdf" target="_blank">Read the report >></a></p></div>Behavioral Health Workforce Reporthttps://hub.nic-us.org/groups/opioid-epidemic/resources/behavioral-health-workforce-report2020-12-21T17:54:40.000Z2020-12-21T17:54:40.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>About:</p>
<p>SAMHSA has released the “Behavioral Health Workforce Report,” which documents effective mental and substance use disorder treatment models and pertinent staffing needs – as part of the agency’s goal to increase access to evidence-based mental and substance use disorder care.</p>
<p><a href="https://www.samhsa.gov/sites/default/files/behavioral-health-workforce-report.pdf" target="_blank">Read the report >></a></p></div>Supporting Children and Families Affected by the Opioid Epidemichttps://hub.nic-us.org/groups/opioid-epidemic/resources/supporting-children-and-families-affected-by-the-opioid-epidemic2020-12-08T18:13:50.000Z2020-12-08T18:13:50.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>In this analysis, we sought to begin to identify how the opioid crisis is affecting children in families touched by problem drug use; how parents or caregivers could be better supported; and how service providers and systems—and the policies underpinning them—could better support families affected by the crisis. To do so, we consulted with national experts in the field and conducted site visits to two Appalachian communities significantly affected by the epidemic. However, the two communities we visited do not represent the wide range of communities and local contexts relevant to this ongoing nationwide epidemic.</p>
<p>The study revealed wide-ranging unmet community needs and service system limitations, often tied to historical policy failures and/or regional economic challenges. People grappling with substance use disorders face limited access to treatment, as do their families, and child-serving systems are often not equipped to meet the complex needs of children and families touched by the epidemic. And though schools and early childhood care programs can be a critical resource for families, these service systems and settings are already overstretched and underfunded. Further, stigma, bias, and misinformation continue to impair efforts to address the epidemic.</p>
<p>Policymakers looking to support children and families and the service systems surrounding them, would do well to</p>
<ul>
<li>address long-standing systems-level challenges and misalignments,</li>
<li>invest in community-based services and infrastructure,</li>
<li>deliver trauma-informed care,</li>
<li>family-proof public policies while also making them more adaptive and agile,</li>
<li>and ensure policies in mainstream settings reflect best practices and research-based evidence.</li>
</ul>
<p><a href="https://www.urban.org/research/publication/supporting-children-and-families-affected-opioid-epidemic" target="_blank">Read the full report >></a></p></div>Combatting the Stigma of Addiction - The Need for a Comprehensive Health System Approachhttps://hub.nic-us.org/groups/opioid-epidemic/resources/combatting-the-stigma-of-addiction-the-need-for-a-comprehensive-h2020-11-16T17:55:31.000Z2020-11-16T17:55:31.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>Highlights:</p>
<ul>
<li>Pre-COVID-19, only 10 percent of those with SUDs received treatment, contributing to the 70,000 annual deaths from drug overdose, of which more than two-thirds are opioid-related. In the current context, the opioid crisis is being acutely aggravated. The pandemic has exacerbated the weaknesses of an already fragile system—a system rife with both individual and structural stigma against patients and medications for treatment—that many individuals with opioid use disorder (OUD) found difficult to enter and navigate. The need to address stigma has never been more pressing.</li>
<li>Barriers at the system level present as restrictive requirements limiting access, coverage, and reimbursement for OUD treatment. Health care policies and payer structures have not been built to treat OUD as a chronic disease, perpetuating gaps in access to and provision of affordable, evidence-based treatment. Complex requirements for practitioner waivers and pre-authorizations can serve as additional barriers, reinforcing continued isolation and stigmatization of treatment.</li>
</ul>
<p><a href="https://nam.edu/combatting-the-stigma-of-addiction-the-need-for-a-comprehensive-health-system-approach/" target="_blank">Read the article >></a></p></div>The American Opioid Epidemic in Special Populations: Five Exampleshttps://hub.nic-us.org/groups/opioid-epidemic/resources/the-american-opioid-epidemic-in-special-populations-five-examples2020-11-03T16:39:45.000Z2020-11-03T16:39:45.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>The United States is in the midst of an unprecedented crisis of prescription and illicit opioid misuse, use disorder, and overdose. In 2018, nearly 47,000 Americans died from an overdose involving opioids [174]. In 2018, 10.3 million people aged 12 years and older reported misusing prescription opioids or using heroin, and 2 million met the diagnostic criteria for having an opioid use disorder in the past year—lower than 2015 through 2017 [150].</p>
<p>Although the crisis has affected large swaths of the U.S. population, it has affected certain segments of the population with an extra level of intensity—justice-involved populations, rural populations, veterans, adolescents and young adults, and persons who inject drugs. Other than for persons who inject drugs, little research to date has been dedicated toward understanding the specific needs of these special populations, including building the evidence base for targeted approaches and solutions. Research has clearly shown that solutions for the opioid overdose epidemic are not one size fits all, and special attention should be paid to these populations that may be suffering unduly. For each identified population, this manuscript reviews why it is an important area of focus, current barriers encountered in accessing care, promising approaches in supporting this population, and high-impact research and action priorities.</p>
<p><a href="https://nam.edu/wp-content/uploads/2020/10/The-American-Opioid-Epidemic-in-Special-Populations.pdf" target="_blank">Read the discussion paper >></a></p>
<p> </p></div>DRUG OVERDOSE AWARENESS & PREVENTIONhttps://hub.nic-us.org/groups/opioid-epidemic/resources/drug-overdose-awareness-prevention2020-10-23T17:33:23.000Z2020-10-23T17:33:23.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>A resource page to raise awareness and provide support in hopes to prevent future overdose cases.</p>
<p><a href="https://shorelinerecoverycenter.com/drug-overdoses/" target="_blank">Read more >></a></p></div>SMART Recoveryhttps://hub.nic-us.org/groups/opioid-epidemic/resources/smart-recovery2020-10-09T16:35:17.000Z2020-10-09T16:35:17.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>What is SMART Recovery?</p>
<p>SMART Recovery stands for Self-Management and Recovery Training. Like AA, the goal of SMART Recovery is to support individuals that choose to give up and abstain from alcohol and substance use. The program is based on current scientific knowledge of addiction, but they commit to evolving the program as researchers learn more about addiction recovery.</p>
<p>The goal of SMART Recovery support groups and meetings is to teach people how to move forward after addiction. They accomplish this by encouraging self-empowerment. Some of the main topics covered in the SMART recovery include:</p>
<ul>
<li>Encouraging self-responsibility, self-discipline, and self-motivation throughout the recovery process.</li>
<li>Teaching how to replace self-destruction thoughts with rational, healthy beliefs.</li>
<li>How to set achievable goals throughout recovery.</li>
<li>Learning coping skills in order to resist urges and reduce negative behavior.</li>
<li>Learning how to accept that impulses and triggers are a natural part of recovery.</li>
<li>Understanding how to deal with triggers when they occur.</li>
<li>Making SMART Recovery lessons and tools a part of everyday life situations.</li>
</ul>
<p><a href="https://alcoholrehabhelp.org/treatment/smart/" target="_blank">Read more >></a></p></div>Addiction Group: Inpatient Rehabhttps://hub.nic-us.org/groups/opioid-epidemic/resources/addiction-group-inpatient-rehab2020-10-06T15:20:07.000Z2020-10-06T15:20:07.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>Inpatient rehab is one of the three most common types of treatment for substance or alcohol use disorders. Patients eat, sleep, and undergo all of their treatments at the inpatient treatment facility.</p>
<p><a href="https://www.addictiongroup.org/treatment/options/inpatient/" target="_blank">Read more >></a></p></div>2019 NSDUH Annual National Reporthttps://hub.nic-us.org/groups/opioid-epidemic/resources/2019-nsduh-annual-national-report2020-09-22T17:28:48.000Z2020-09-22T17:28:48.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>Description:</p>
<p>This report summarizes key findings from the 2019 National Survey on Drug Use and Health (NSDUH) for national indicators of substance use and mental health among people aged 12 years old or older in the civilian, noninstitutionalized population of the United States.</p>
<p><a href="https://www.samhsa.gov/data/report/2019-nsduh-annual-national-report" target="_blank">Read the report >></a></p></div>Addiction Group: Alcohol Effects, Addiction Treatment, and Resourceshttps://hub.nic-us.org/groups/opioid-epidemic/resources/addiction-group-alcohol-effects-addiction-treatment-and-resources2020-09-18T18:20:37.000Z2020-09-18T18:20:37.000ZHub Adminhttps://hub.nic-us.org/members/NIC<div><p>There are many different treatment options for people who suffer from drug or alcohol addiction. Addiction Group's comprehensive rehabilitation resource center will help you find the best treatment options for you or your loved one.</p>
<p><a href="https://www.addictiongroup.org/rehab/" target="_blank">Read more >></a></p></div>Can EHR Natural Language Processing Detect Opioid Misuse Codes?https://hub.nic-us.org/groups/opioid-epidemic/resources/can-ehr-natural-language-processing-detect-opioid-misuse-codes2020-09-14T15:22:29.000Z2020-09-14T15:22:29.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>Human reviewers could identify roughly 70 percent more patients with an opioid use disorder (OUD) than an EHR algorithm.</p>
<p><a href="https://ehrintelligence.com/news/can-ehr-natural-language-processing-detect-opioid-misuse-codes?eid=CXTEL000000590793&elqCampaignId=15884&utm_source=nl&utm_medium=email&utm_campaign=newsletter&elqTrackId=96e60c6874db4474a70ed4b7c01edb99&elq=16b3626d85a94aaf96ee99264614aeab&elqaid=16660&elqat=1&elqCampaignId=15884" target="_blank">Read more >></a></p></div>Payer Empowers Grassroots Movement to Tackle Opioids Epidemichttps://hub.nic-us.org/groups/opioid-epidemic/resources/payer-empowers-grassroots-movement-to-tackle-opioids-epidemic2020-09-14T15:14:37.000Z2020-09-14T15:14:37.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>A passion for providing substance abuse care and patient advocacy at Highmark Health has created a movement to empower reform around the opioids epidemic.</p>
<p><a href="https://healthpayerintelligence.com/news/payer-empowers-grassroots-movement-to-tackle-opioids-epidemic?eid=CXTEL000000590793&elqCampaignId=15904&utm_source=nl&utm_medium=email&utm_campaign=newsletter&elqTrackId=88e48daee7eb4ca6b23b6a44a7346554&elq=bc27c8735ae94ea5a2daf71e27799a4b&elqaid=16667&elqat=1&elqCampaignId=15904" target="_blank">Read the article >></a></p></div>Best Practices, Research Gaps, and Future Priorities to Support Tapering Patients on Long-Term Opioid Therapy for Chronic Non-Cancer Pain in Outpatient Settingshttps://hub.nic-us.org/groups/opioid-epidemic/resources/best-practices-research-gaps-and-future-priorities-to-support-tap2020-08-22T19:50:12.000Z2020-08-22T19:50:12.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>This paper focuses on the best practices based on available evidence and research gaps across the key steps in the tapering process:</p>
<ul>
<li>Review of indications for an opioid taper</li>
<li>Shared decision-making and patient engagement when tapering opioids</li>
<li>Selecting the speed of an opioid taper</li>
<li>Considerations and potential approaches when tapering opioids
<ul>
<li>Use of non-opioid pharmacological therapy and non-pharmacological therapies to ensure comprehensive pain management</li>
<li>Managing withdrawal symptoms</li>
<li>Approaches to managing a challenging taper</li>
<li>Tapering a patient who is co-prescribed opioid analgesics, benzodiazepines, and other central nervous system depressants</li>
</ul>
</li>
<li>Priorities for future research</li>
</ul>
<p><a href="https://nam.edu/wp-content/uploads/2020/08/Best-Practices-Research-Gaps-and-Future-Priorities-Tapering-FINAL.pdf" target="_blank">Read more >></a></p></div>California Youth Opioid Projecthttps://hub.nic-us.org/groups/opioid-epidemic/resources/california-youth-opioid-project2020-08-20T18:13:19.000Z2020-08-20T18:13:19.000ZDaniel Bachhttps://hub.nic-us.org/members/DanielBach<div><p><span style="font-size:12pt;"><em>A Joint Effort by the California Institute for Behavioral Health Solutions and Advocates for Human Potential, Inc. and funded by the California Department of Health Care Services Community Services Division, established a collection of protocols, toolkits, and guidance materials supporting federal, state, and community-based agencies’ efforts to implement best practices leading to systems change, improved outcomes, enhanced access, and improved delivery of prevention, treatment, and recovery services to California’s youth with, or at risk of, an opioid use disorder and their families. </em></span></p><p> </p><p><span style="font-size:12pt;"><a href="https://www.cibhs.org/sites/main/files/file-attachments/professionalresourcesupdate_0720.pdf?1595962320" target="_blank">Full List:</a></span></p></div>The Opioid Crisis and the Hispanic/Latino Population: An Urgent Issuehttps://hub.nic-us.org/groups/opioid-epidemic/resources/the-opioid-crisis-and-the-hispanic-latino-population-an-urgent-is2020-08-13T17:38:14.000Z2020-08-13T17:38:14.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>The Opioid Crisis and the Hispanic/Latino Poplution issue brief presents data on prevalence of opioid misuse & death rates in the Hispanic/Latino population; contextual factors & challenges to prevention & treatment; innovative outreach & engagement strategies to connect people to evidence-based treatment; and the importance of community voice.</p>
<p><a href="https://store.samhsa.gov/product/The-Opioid-Crisis-and-the-Hispanic-Latino-Population-An-Urgent-Issue/PEP20-05-02-002?referer=from_search_result" target="_blank">Read more >></a></p></div>How Online Rehab and Virtual Recovery Workshttps://hub.nic-us.org/groups/opioid-epidemic/resources/how-online-rehab-and-virtual-recovery-works2020-07-30T13:00:52.000Z2020-07-30T13:00:52.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>With everything going on in the world right now, the DecisionData.org team realized that people seeking rehab may be struggling to get help. They decided to create a page that covers everything needed to know about online rehab so people can still find the help they need.</p><p>Their resource goes over how online rehab works, who can benefit from it, and also goes over the leading online rehab centers so readers can find one that works for them.</p><p><a href="https://decisiondata.org/news/online-rehab/" target="_blank">Read more >></a></p></div>Virtual recovery resourceshttps://hub.nic-us.org/groups/opioid-epidemic/resources/virtual-recovery-resources2020-05-05T14:03:27.000Z2020-05-05T14:03:27.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>The coronavirus pandemic has made it difficult for those recovering from substance abuse to continue recovery programs. Substance Abuse and Mental Health Services Administration (SAMSHA) recently released a tip sheet that provides resources that can be used to virtually support recovery from mental/substance use disorders.</p><p><a href="https://www.samhsa.gov/sites/default/files/virtual-recovery-resources.pdf" target="_blank">Read the tip sheet >></a></p></div>Patient-Reported Opioid Pill Consumption After an ED Visit: How Many Pills Are People Using?https://hub.nic-us.org/groups/opioid-epidemic/resources/patient-reported-opioid-pill-consumption-after-an-ed-visit-how-ma2020-05-05T13:49:21.000Z2020-05-05T13:49:21.000ZAmanda Taylorhttps://hub.nic-us.org/members/AmandaTaylor<div><p>AHRQ recently released the findings of an opioid study that they funded. AHRQ shared that the study "looked at how many opioid pills are being prescribed during an emergency department visit for acute pain and how many patients actually use. The researchers found that the median number of pills prescribed was 12 and that 92.5% of patients had pills left over 10 days after the visit; however, there was considerable variation by cause of pain."</p><p><a href="https://www.ahrq.gov/sites/default/files/wysiwyg/opioids/mccarthy-painmed-opioid-pill-use.pdf" target="_blank">Read the study >></a></p></div>Opioid Addiction Is 'A Disease Of Isolation,' So Pandemic Puts Recovery At Riskhttps://hub.nic-us.org/groups/opioid-epidemic/resources/opioid-addiction-is-a-disease-of-isolation-so-pandemic-puts-recov2020-04-06T15:41:44.000Z2020-04-06T15:41:44.000ZNavah Steinhttps://hub.nic-us.org/members/NavahStein<div><p><span style="font-weight:400;">While staying home may be the safer way to avoid getting and spreading COVID-19, addiction specialists acknowledge Emma's concern: Doing so may increase feelings of depression and anxiety among people in recovery — and those are underlying causes of drug and alcohol use and addiction...</span><span style="font-weight:400;">"We consider addiction a disease of isolation," says Dr. Marvin Seppala, chief medical officer at the Hazelden Betty Ford Foundation. "Now we're isolating all these people and expecting them to pick up the phone, get on line, that sort of thing — and it may not work out as well."</span></p><p><span style="font-weight:400;"><a href="http://https//www.npr.org/sections/health-shots/2020/03/27/820806440/opioid-addiction-is-a-disease-of-isolation-so-pandemic-puts-recovery-at-risk" target="_blank">Read More >></a></span></p></div>Medication-Assisted Treatment (MAT) for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkithttps://hub.nic-us.org/groups/opioid-epidemic/resources/medication-assisted-treatment-mat-for-opioid-use-disorder-in-ja-12020-03-10T18:13:11.000Z2020-03-10T18:13:11.000ZNavah Steinhttps://hub.nic-us.org/members/NavahStein<div><p>People who have been incarcerated are approximately 100 times more likely to die by overdose in the first two weeks after their release than the general public. Despite high rates of opioid use disorder among justice-involved individuals, evidence-based medications exist and can be successfully implemented within jails and prisons. To reduce risk of opioid overdose and recidivism and to better serve incarcerated individuals with opioid use disorder, the National Council, in partnership with Vital Strategies and faculty from Johns Hopkins University, developed a new resource guide titled: <strong><em><a title="A link to a .pdf file." href="https://www.thenationalcouncil.org/wp-content/uploads/2020/01/MAT_in_Jails_Prisons_Toolkit_Final_2020-01-30.pdf" target="_blank">Medication-Assisted Treatment for Opioid Use Disorder in Jails and Prisons: A Planning and Implementation Toolkit</a>.</em></strong></p><p>This toolkit...provides correctional administrators and health care providers recommendations and tools for implementing medication-assisted treatment (MAT) in correctional settings and strategies for overcoming challenges. Informed by real-world practice, the toolkit provides examples from the field that can be widely applied and adapted.</p><p><a href="https://www.thenationalcouncil.org/wp-content/uploads/2020/01/MAT_in_Jails_Prisons_Toolkit_Final_2020-01-30.pdf" target="_blank">Read More >></a></p></div>Association of Medicaid Expansion With Opioid Overdose Mortality in the United Stateshttps://hub.nic-us.org/groups/opioid-epidemic/resources/association-of-medicaid-expansion-with-opioid-overdose-mortality-2020-02-27T17:21:12.000Z2020-02-27T17:21:12.000ZNavah Steinhttps://hub.nic-us.org/members/NavahStein<div><p><strong>Importance</strong> The Patient Protection and Affordable Care Act (ACA) permits states to expand Medicaid coverage for most low-income adults to 138% of the federal poverty level and requires the provision of mental health and substance use disorder services on parity with other medical and surgical services. Uptake of substance use disorder services with medications for opioid use disorder has increased more in Medicaid expansion states than in nonexpansion states, but whether ACA-related Medicaid expansion is associated with county-level opioid overdose mortality has not been examined.</p><p><strong>Objective</strong> To examine whether Medicaid expansion is associated with county × year counts of opioid overdose deaths overall and by class of opioid.</p><p><a href="https://jamanetwork.com/journals/jamanetworkopen/article-abstract/2758476?blm_aid=287744&blm_aid=4833281" target="_blank">Read More >></a></p></div>Regional and temporal effects of naloxone access laws on opioid overdose mortalityhttps://hub.nic-us.org/groups/opioid-epidemic/resources/regional-and-temporal-effects-of-naloxone-access-laws-on-opioid-o2020-02-27T17:18:56.000Z2020-02-27T17:18:56.000ZNavah Steinhttps://hub.nic-us.org/members/NavahStein<div><div class="hlFld-Abstract test"><div class="sectionInfo abstractSectionHeading"><div class="sectionHeading">Abstract</div></div><div class="abstractSection abstractInFull"><p><em>Background:</em> Naloxone is a drug that reverses opioid overdose. Naloxone Access Laws (NALs) increase public access to naloxone and have been considered as one promising solution to reducing opioid-related harm. However, previous studies on whether NALs are effective in reducing opioid overdose mortality found somewhat contradictory results. Our study attempts to provide a more definitive answer to this question by utilizing an approach that matches NAL vs non-NAL states and stratifies by US region and years of implementation. <em>Methods:</em> We assess the causal impact of NALs on state-level opioid-related mortality rate by constructing a comparison group using matching to produce a valid counterfactual scenario, and estimating the effects of NAL using a semi-dynamic staggered difference in differences (DID) model that allows heterogeneous effects across regions and years of implementation. State-level opioid-related mortality data from CDC’s WONDER database and NALs effective from 1999 to 2014 were utilized. <em>Results:</em> We find that NAL effects have reduced fatal opioid-related overdose in western states and have produced minimal or no effects for other regions. <em>Conclusions:</em> The effects of NALs vary across regions and years of implementation. It is important to study the successful experience of the western states.</p></div></div><p><a href="https://www.tandfonline.com/doi/abs/10.1080/08897077.2019.1709605?scroll=top&needAccess=true&journalCode=wsub20&blm_aid=4833281&" target="_blank">Read More >></a></p></div>States May Soon Have to Provide Medication-Assisted Treatment to Inmates, Here’s How to Fund Ithttps://hub.nic-us.org/groups/opioid-epidemic/resources/states-may-soon-have-to-provide-medication-assisted-treatment-to-2020-02-27T17:12:48.000Z2020-02-27T17:12:48.000ZNavah Steinhttps://hub.nic-us.org/members/NavahStein<div><p>State policymakers on the frontlines of the opioid epidemic understand that treating justice-involved individuals with opioid use disorder (OUD) offers a critical opportunity to expand access to treatment. While there is strong <a href="https://store.samhsa.gov/system/files/pep19-matbriefcjs.pdf">evidence</a> that medication-assisted treatment (MAT) promotes recovery, saves <a href="https://jamanetwork.com/journals/jamapsychiatry/article-abstract/2671411">lives</a>, and reduces re-incarceration, states must surmount significant policy and financial challenges to provide MAT in correctional settings...</p><p><a href="https://nashp.org/states-may-soon-have-to-provide-medication-assisted-treatment-to-inmates-heres-how-to-fund-it/" target="_blank">Read More >></a></p></div>Medication-Assisted Treatment for Opioid Use Disorder Playbookhttps://hub.nic-us.org/groups/opioid-epidemic/resources/medication-assisted-treatment-for-opioid-use-disorder-playbook2020-02-27T17:09:28.000Z2020-02-27T17:09:28.000ZNavah Steinhttps://hub.nic-us.org/members/NavahStein<div><p>The AHRQ Academy developed the Medication-Assisted Treatment for Opioid Use Disorder Playbook (referred to as the MAT for OUD Playbook), a practical guide for implementing MAT in primary care and other ambulatory care settings. While the Playbook aims to help providers in rural primary care, the information in the Playbook should apply to other ambulatory care settings. This interactive, web-based product has the latest guidance, tools, and resources that address key aspects of implementation.</p><p>The MAT for OUD Playbook aims to address the growing need for guidance as more primary care practices and health systems begin to implement MAT. The Playbook’s framework is designed to be useful for practices implementing any array of MAT services.</p><p><a href="https://integrationacademy.ahrq.gov/products/mat-playbook/medication-assisted-treatment-opioid-use-disorder-playbook?utm_source=ahrq&utm_medium=en-2&utm_term=Opioid_Playbook&utm_content=2&utm_campaign=ahrq_en10_01_2019" target="_blank">Read More >></a></p></div>Deterra Drug Deactivation Systemhttps://hub.nic-us.org/groups/opioid-epidemic/resources/deterra-drug-deactivation-system2020-02-27T17:05:56.000Z2020-02-27T17:05:56.000ZNavah Steinhttps://hub.nic-us.org/members/NavahStein<div><div class="vc_row wpb_row vc_row-fluid"><div class="wpb_column vc_column_container vc_col-sm-12"><div class="vc_column-inner"><div class="wpb_wrapper"><div class="wpb_text_column wpb_content_element"><div class="wpb_wrapper"><p>Minneapolis based Verde® Technologies, Inc., is a privately owned company committed to developing research based scientifically proven solutions to reduce drug abuse, misuse and negative environmental impact. The patented Deterra® Drug Deactivation System is powered by proprietary MAT<sub>12</sub>® Molecular Adsorption Technology, which deactivates drugs using activated carbon. Deterra is highly effective in adsorbing and firmly binding drugs, rendering them inert, unavailable for misuse and safe for the environment.</p></div></div></div></div></div></div><p><a href="https://deterrasystem.com/" target="_blank">Read More >></a></p></div>Local Health Department Approaches to Opioid Use Prevention and Response: An Environmental Scanhttps://hub.nic-us.org/groups/opioid-epidemic/resources/local-health-department-approaches-to-opioid-use-prevention-and-r2020-02-27T16:57:26.000Z2020-02-27T16:57:26.000ZNavah Steinhttps://hub.nic-us.org/members/NavahStein<div><p>Despite these efforts, there is a lack of information about how Local Health Departments (LHDs) are conducting opioid prevention and response activities and a lack of access to case studies and evidence-based best practices to guide LHDs seeking examples of experienced programs. In an initial attempt to learn more, the National Association of County and City Health Officials (NACCHO) included questions about opioids in their biannual 2018 Forces of Change Study and found that about two-thirds of LHDs actively addressed the opioid crisis in 2017. While a few other data points on the subject were collected, NACCHO identified a further need to dive deeper and document the range of activities LHDs conduct by administering an environmental scan. The goal of the scan was to create a foundational understanding of LHD opioid overdose prevention and response efforts to inform priorities at the local, state, and national levels. <a href="https://www.naccho.org/uploads/downloadable-resources/Environmental-Scan-V3-July-2019-FINAL-v2.pdf" target="_blank">Read More >></a></p></div>Templates for LHD Opioid Prevention & Response: A How-To Guidehttps://hub.nic-us.org/groups/opioid-epidemic/resources/templates-for-lhd-opioid-prevention-response-a-how-to-guide2020-02-27T16:53:36.000Z2020-02-27T16:53:36.000ZNavah Steinhttps://hub.nic-us.org/members/NavahStein<div><p>The National Association of County and City Health Officials (NACCHO) is dedicated to increasing local health department (LHD) capacity to respond effectively to the opioid epidemic. This How-To Guide is a reference document to support LHDs as they plan for, implement, and evaluate their efforts by utilizing NACCHO’s Action Plan, Budget Plan, and Evaluation Plan templates. The templates can be found in NACCHO’s online Opioid Epidemic Toolkit for LHDs.</p><p><a href="https://www.naccho.org/uploads/downloadable-resources/LHD-Opioid-Templates-How-To-Guide.pdf" target="_blank">Read More >></a></p></div>